426 related articles for article (PubMed ID: 17508187)
1. Pain pharmacology in migraine: focus on CGRP and CGRP receptors.
Benemei S; Nicoletti P; Capone JA; Geppetti P
Neurol Sci; 2007 May; 28 Suppl 2():S89-93. PubMed ID: 17508187
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
3. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
Link AS; Kuris A; Edvinsson L
J Headache Pain; 2008 Feb; 9(1):5-12. PubMed ID: 18217201
[TBL] [Abstract][Full Text] [Related]
4. CGRP antagonists in the acute treatment of migraine.
Lipton RB; Dodick DW
Lancet Neurol; 2004 Jun; 3(6):332. PubMed ID: 15157847
[No Abstract] [Full Text] [Related]
5. The tortuous road to an ideal CGRP function blocker for the treatment of migraine.
Davis CD; Xu C
Curr Top Med Chem; 2008; 8(16):1468-79. PubMed ID: 18991732
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
Hargreaves R; Olesen J
Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
[TBL] [Abstract][Full Text] [Related]
7. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide (CGRP): a new target for migraine.
Russo AF
Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
[TBL] [Abstract][Full Text] [Related]
9. CGRP and migraine: neurogenic inflammation revisited.
Geppetti P; Capone JG; Trevisani M; Nicoletti P; Zagli G; Tola MR
J Headache Pain; 2005 Apr; 6(2):61-70. PubMed ID: 16362644
[TBL] [Abstract][Full Text] [Related]
10. Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
Tfelt-Hansen PC
J Headache Pain; 2009 Dec; 10(6):389-91. PubMed ID: 19779958
[TBL] [Abstract][Full Text] [Related]
11. CGRP receptor antagonists: a new choice for acute treatment of migraine?
Durham PL
Curr Opin Investig Drugs; 2004 Jul; 5(7):731-5. PubMed ID: 15298069
[TBL] [Abstract][Full Text] [Related]
12. CGRP receptor antagonists: toward a novel migraine therapy.
Salvatore CA; Kane SA
Curr Pharm Biotechnol; 2011 Oct; 12(10):1671-80. PubMed ID: 21466447
[TBL] [Abstract][Full Text] [Related]
13. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide and its role in migraine pathophysiology.
Arulmani U; Maassenvandenbrink A; Villalón CM; Saxena PR
Eur J Pharmacol; 2004 Oct; 500(1-3):315-30. PubMed ID: 15464043
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide (CGRP) antagonists: blockers of neuronal transmission in migraine.
Brain SD
Br J Pharmacol; 2004 Aug; 142(7):1053-4. PubMed ID: 15237096
[TBL] [Abstract][Full Text] [Related]
16. The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
Holland PR; Saengjaroentham C; Vila-Pueyo M
Cephalalgia; 2019 Mar; 39(3):390-402. PubMed ID: 29411638
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Messlinger K; Fischer MJ; Lennerz JK
Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
Bigal ME; Walter S; Rapoport AM
Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.
Giniatullin R; Nistri A; Fabbretti E
Mol Neurobiol; 2008 Feb; 37(1):83-90. PubMed ID: 18459072
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic Migraine.
Yuan H; White CS; Silberstein SD
Clin Pharmacol Ther; 2019 May; 105(5):1121-1129. PubMed ID: 30648737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
